Bicycle Therapeutics Announces Expansion of Scientific Advisory Board

Dovie Salais

– Four renowned experts join to advise Bicycle as the company advances pipeline of novel cancer therapeutic candidates Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle┬«) technology, today announced that leaders in the fields of oncology, […]

Subscribe US Now